Research article · 14 Apr 2026
Conference abstractPublished 2 Nov 2016
Correlation between antifungals susceptibility of Cryptococcus spp. and outcome of patients with HIV/ AIDS with cryptococcal meningitis
Adolfo Lutz Institute, Brazil Emilio Ribas Research Institute, Brazil
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cryptococcal meningitis is one of the most common opportunistic infections (OIs) in HIV patients and affects one million people per year worldwide, resulting in 625,000 deaths. The aim of our study was to examine the association between the clinical and laboratorial findings of cryptococcal meningitis cases with antifungal minimum inhibitory concentration (MICs) and molecular types of the etiological agents and risk factors associated with in-hospital mortality. Data from 34 patients were reviewed, retrospectively. Regarding the susceptibility test for fluconazole (FLU), using a cutoff of 8 Ã?¼g/mL and 16 Ã?¼g/mL, there were no significant differences between clinical presentation, cytological analyses of CSF, time to sterilize the CSF, isolation of fungus at another site, molecular type, previous diagnosis of cryptococcal meningitis or the use of FLU and overall mortality. There was a statistical association between mortality and patients who did not have sterilized CSF (p=0.002) when lacking of neurosurgical shunt (p=0.021) and in those who presented with other OIs (p=0.037). In addition, patients who died presented with a higher yeast count (median 1720 cells/mcL) in the first CSF level than those who survived (median 351 cells/mcL) (p=0.021). Patients who presented with yeast cell counts >400/mm3 were associated with greater lethality when compared with âÂ?¤400 (p=0.014). We concluded that cryptococcal meningitis is difficult to manage and that the aspects associated with greater mortality should be analyzed carefully. The clinical role of MIC is uncertain, and there is no good evidence for its use in routine practice.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Infectious Diseases & Therapy.
Research article · 5 May 2025
The Ultimate Cure for the COVID Syndemic
Mini review · 29 Apr 2025
COVID-19 Systematic Mini-Review as of April 2025
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Therapy
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Marcia de Souza Carvalho Melhem”
- BylineArticles whose byline prints “Oscar Jose Chagas”
- BylineArticles whose byline prints “Renata Buccheri”
- BylineArticles whose byline prints “Maria Walderez Szeszs”
- BylineArticles whose byline prints “Marilena dos Anjos Martins”
- BylineArticles whose byline prints “Lidiane de Oliveira”
- BylineArticles whose byline prints “Dulcilena de Matos Castro e Silva”
- BylineArticles whose byline prints “Daniel Wagner de Castro Lima Santos”